Thus, by inhibiting the NR4A1/DNA-PKcs/p53 pathway, melatonin improves mitochondrial function and largely reverses the pathogenesis of HFD-induced NAFLD. This evidence concerns the gene NR4A1 and metabolic dysfunction-associated steatotic liver disease.